Batu Biologics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Batu Biologics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10940
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Batu Biologics Inc (Batu Biologics) is an immuno-oncology company. The company offers development and commercialization of novel therapies that target the Achilles Heel of cancer: the tumor blood vessels. Its lead product ValloVax is a cellular anti-angiogenic cancer vaccine that is developed to induce an immune response against the tumor endothelium of non small cell lung cancer. Batu Biologics’ pipeline products include Immitam, DendroVax, and ImmXcyte. The company’s products find application in treating of cancers such as lung cancer, glioblastoma, and all other solid tumors. Its in partnership with academic institutions carries research work in the field of cancer immunotherapy. The company operates a research facility located at Janssen Research and Development in California, the US. Batu Biologics is headquartered in San Diego, California, the US.

Batu Biologics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Batu Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Batu Biologics Raises USD1.3 Million in Venture Financing 10
Batu Biologics Raises USD0.1 Million in Venture Financing 11
Batu Biologics Raises USD0.35 Million in Venture Financing 12
Batu Biologics Raises USD1 Million in Seed Financing 13
Batu Biologics Raises USD0.1 Million in Venture Financing 14
Licensing Agreements 15
Batu Biologics Enters into Licensing Agreement with University of California, San Diego 15
Batu Biologics Inc – Key Competitors 16
Batu Biologics Inc – Key Employees 17
Batu Biologics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Mar 24, 2018: Appoints Dr. Francesco Marincola As Clinical Advisory Board Chairman 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Batu Biologics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Batu Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Batu Biologics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Batu Biologics Raises USD1.3 Million in Venture Financing 10
Batu Biologics Raises USD0.1 Million in Venture Financing 11
Batu Biologics Raises USD0.35 Million in Venture Financing 12
Batu Biologics Raises USD1 Million in Seed Financing 13
Batu Biologics Raises USD0.1 Million in Venture Financing 14
Batu Biologics Enters into Licensing Agreement with University of California, San Diego 15
Batu Biologics Inc, Key Competitors 16
Batu Biologics Inc, Key Employees 17
Batu Biologics Inc, Other Locations 18

List of Figures
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Batu Biologics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oversea-Chinese Banking Corp Ltd:企業の戦略・SWOT・財務情報
    Oversea-Chinese Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Oversea-Chinese Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Anek Lines SA:企業の戦略・SWOT・財務情報
    Anek Lines SA - Strategy, SWOT and Corporate Finance Report Summary Anek Lines SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Banco Pan SA (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan SA (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Auswide Bank Ltd (ABA):企業の財務・戦略的SWOT分析
    Auswide Bank Ltd (ABA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Pt Bank Central Asia Tbk
    Pt Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kenra Professional, LLC:企業の戦略・SWOT・財務情報
    Kenra Professional, LLC - Strategy, SWOT and Corporate Finance Report Summary Kenra Professional, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Edison SpA (EDNR):企業の財務・戦略的SWOT分析
    Edison SpA (EDNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sing Investments & Finance Ltd (S35):企業の財務・戦略的SWOT分析
    Sing Investments & Finance Ltd (S35) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Samba Financial Group (1090):企業の財務・戦略的SWOT分析
    Samba Financial Group (1090) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • CytomX Therapeutics Inc (CTMX):製薬・医療:M&Aディール及び事業提携情報
    Summary CytomX Therapeutics Inc (CytomX) is a clinical-stage biopharmaceutical company which develops novel therapeutic antibodies and Probody therapeutics for the treatment of cancer. The company’s leading product candidates include CX-072, CX-2009, BMS-986249, CX-2029, CX-188, probody drug conjuga …
  • SpineGuard SA (ALSGD):医療機器:M&Aディール及び事業提携情報
    Summary SpineGuard SA (SpineGuard) is a medical device company that designs, develops and markets spine surgery products. The company offers PediGuard, a device that detects possible vertebral cortex perforation during pedicle preparation. It provides offers screw placement and alerts to surgeon pri …
  • Unity Biotechnology Inc (UBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Unity Biotechnology Inc (Unity Biotechnology), formerly Forge Inc is a biotechnology company that researches, develops and commercializes therapeutics for the treatment of age-related diseases. The company focuses on the development of senolytic medicines to eliminate senescent cells. The co …
  • Genisphere LLC:医療機器:M&Aディール及び事業提携情報
    Summary Genisphere LLC (Genisphere) is a nanotechnology company that provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapeutics. It develops pipeline product …
  • University of Tennessee Research Foundation-製薬・医療分野:企業M&A・提携分析
    Summary University of Tennessee Research Foundation (UTRF), a subsidiary of University of Tennessee is a non profit organization that promotes research and education. The organization offers agriculture, chemistry and materials; energy, animal health, engineering, human health, research tools and so …
  • Japan Pulp and Paper Co Ltd:戦略・SWOT・企業財務分析
    Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • NorthWestern Corporation (NWE)-エネルギー分野:企業M&A・提携分析
    Summary NorthWestern Corporation, doing business as NorthWestern Energy, is an integrated electric utility which generates, transmits, and distributes electricity and distributes natural gas in South Dakota, Nebraska and Montana. It produces energy from wind, hydro, natural gas, and coal-fired sourc …
  • Ahn-Gook Pharmaceutical Co Ltd (001540)-製薬・医療分野:企業M&A・提携分析
    Summary Ahn-Gook Pharmaceutical Co Ltd (Ahn-Gook Pharmaceutical) is a developer and supplier of medicines. The company provides health functional food, medical device, ethical drug, over the counter drugs, and others. Its products include acefenac tab, ahngook carvedilol tab, ahngook cefaclor cap, a …
  • Minoan Group Plc:企業の戦略・SWOT・財務情報
    Minoan Group Plc - Strategy, SWOT and Corporate Finance Report Summary Minoan Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Clean Harbors Inc (CLH):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Harbors Inc (Clean Harbors) is a provider of environmental, industrial and energy services. The company offers waste disposal and recycling, emergency response, chemical packing, field services, production services, exploration services, directional boring, lodging services and onsite …
  • Visser & Smit Hanab BV:企業の戦略的SWOT分析
    Visser & Smit Hanab BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆